# Food Supplements Based on Nettle and Peppermint to Control Signs and Symptoms Induced by Cancer Therapies

> **NCT04474951** · NA · UNKNOWN · sponsor: **IRCCS Azienda Ospedaliero-Universitaria di Bologna** · enrollment: 60 (estimated)

## Conditions studied

- Breast Cancer
- Gynecologic Cancer

## Interventions

- **DIETARY_SUPPLEMENT:** Stinging Nettle
- **DIETARY_SUPPLEMENT:** Stinging Nettle
- **DIETARY_SUPPLEMENT:** Peppermint

## Key facts

- **NCT ID:** NCT04474951
- **Lead sponsor:** IRCCS Azienda Ospedaliero-Universitaria di Bologna
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-06-20
- **Primary completion:** 2021-03-01
- **Final completion:** 2021-09-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2020-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04474951

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04474951, "Food Supplements Based on Nettle and Peppermint to Control Signs and Symptoms Induced by Cancer Therapies". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04474951. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*